MKI67 and neuroendocrine carcinoma: In a study on 204 patients with gastroenteropancreatic (GEP) NEN G−3, 18% patients presented with a NET G−3 and median Ki−67 was 30%, whereas median Ki−67 was 80% for the 167 patients with NEC [12].